Pacific Edge rises as wider sharemarket stutters

Pacific Edge rises as wider sharemarket stutters
Pacific Edge's chances of a lifeline with Obamacare lifted its share price. (Image: Getty)
Graham Skellern
Pacific Edge made a rapid recovery, rising more than 110% after receiving a reprieve on funding for its Cxbladder tests in the United States, while an uncertain New Zealand sharemarket had its first fall in eight trading days.The S&P/NZX 50 Index wavered in the afternoon and closed at 11,959.33, down 43.13 points or 0.36% after reaching an intraday high of 12,055.2.Market sentiment also softened across the Tasman with the Australian S&P/ASX 200 Index falling 1.29% to 7159.6 points by 6pm NZ time.There were 53 gainers and 79 decliners on...

More Markets

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.